Jingjing Chen
Affiliations: | Dana-Farber Cancer Institute, Boston, MA, United States |
Area:
adipocyte metabolismGoogle:
"Jingjing Chen"Parents
Sign in to add mentor| Andrea Alimonti | grad student | 2011-2019 | ETH Zürich |
| Bruce Spiegelman | post-doc | 2020- | Dana-Farber Cancer Institute |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Colucci M, Zumerle S, Bressan S, et al. (2024) Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells. Cancer Cell |
| Alajati A, D'Ambrosio M, Troiani M, et al. (2020) CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. The Journal of Clinical Investigation |
| Sgrignani J, Chen J, Alimonti A, et al. (2018) How phosphorylation influences E1 subunit pyruvate dehydrogenase: A computational study. Scientific Reports. 8: 14683 |
| Chen J, Guccini I, Di Mitri D, et al. (2018) Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nature Genetics |
| Chen J, Guccini I, Mitri DD, et al. (2018) Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nature Genetics |
| Revandkar A, Perciato ML, Toso A, et al. (2016) Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence. Nature Communications. 7: 13719 |
| Matic I, Revandkar A, Chen J, et al. (2016) Identification of Salvia haenkei as gerosuppressant agent by using an integrated senescence-screening assay. Aging |
| Kalathur M, Toso A, Chen J, et al. (2015) A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours. Nature Communications. 6: 7227 |